Fresenius Medical Care AG & Co. (NYSE:FMS) Downgraded by ValuEngine to Sell

Share on StockTwits

ValuEngine lowered shares of Fresenius Medical Care AG & Co. (NYSE:FMS) from a hold rating to a sell rating in a research note issued to investors on Wednesday, October 17th.

Several other equities analysts also recently commented on the stock. Zacks Investment Research downgraded shares of Fresenius Medical Care AG & Co. from a hold rating to a sell rating in a report on Friday, August 3rd. Royal Bank of Canada reiterated a neutral rating on shares of Fresenius Medical Care AG & Co. in a report on Friday, August 17th. Bank of America started coverage on shares of Fresenius Medical Care AG & Co. in a report on Monday, July 9th. They issued a buy rating on the stock. HSBC upgraded shares of Fresenius Medical Care AG & Co. from a hold rating to a buy rating in a report on Tuesday, August 28th. Finally, DZ Bank reiterated a buy rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, August 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $67.33.

FMS traded down $1.28 during trading on Wednesday, reaching $40.07. 477,012 shares of the stock were exchanged, compared to its average volume of 322,843. The company has a market cap of $26.46 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 1.91 and a beta of 1.10. Fresenius Medical Care AG & Co. has a twelve month low of $38.43 and a twelve month high of $57.94. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 0.41.

Several large investors have recently added to or reduced their stakes in the business. Sustainable Insight Capital Management LLC bought a new stake in shares of Fresenius Medical Care AG & Co. in the third quarter valued at about $243,000. Crossmark Global Holdings Inc. boosted its position in shares of Fresenius Medical Care AG & Co. by 11.0% in the third quarter. Crossmark Global Holdings Inc. now owns 56,248 shares of the company’s stock valued at $2,892,000 after acquiring an additional 5,582 shares during the period. MML Investors Services LLC bought a new stake in shares of Fresenius Medical Care AG & Co. in the third quarter valued at about $256,000. Rhumbline Advisers bought a new stake in shares of Fresenius Medical Care AG & Co. in the third quarter valued at about $263,000. Finally, JPMorgan Chase & Co. boosted its position in shares of Fresenius Medical Care AG & Co. by 3.4% in the third quarter. JPMorgan Chase & Co. now owns 87,216 shares of the company’s stock valued at $4,484,000 after acquiring an additional 2,854 shares during the period. Hedge funds and other institutional investors own 2.46% of the company’s stock.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA provides products and services for patients with chronic kidney failure. The company’s products include dialysis machines, dialyzers and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis.

Further Reading: What is the NASDAQ Stock Market?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.